BIT 0.00% 1.9¢ biotron limited

Award winning BIT, page-3

  1. 8,688 Posts.
    lightbulb Created with Sketch. 552
    just got an email from michelle miller advising of the award

    here is the body of the email

    Dr Carolyn Luscombe, Head of Research and Development, has received an award at the HIV DART and Emerging Viruses 2018 in Miami, Florida for the presentation entitled
    “BIT225-009: Significant Immunological Outcomes after 12 weeks of BIT225 and Antiretroviral Therapy in an HIV-1 Phase 2 Clinical Trial”.
    The award is an acknowledgement of the importance of the outcomes from the Phase 2 trial data presented, as well as the robustness of the science underlying the Company’s programs.
    "

    Well done MM and Carolyn.

    I will buy when I see fit, dyor
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.